Literature DB >> 29769200

Long-Chain n-3 Fatty Acids Attenuate Oncogenic KRas-Driven Proliferation by Altering Plasma Membrane Nanoscale Proteolipid Composition.

Natividad R Fuentes1,2, Mohamed Mlih3, Rola Barhoumi4, Yang-Yi Fan1, Paul Hardin5, Trevor J Steele6, Spencer Behmer6, Ian A Prior7, Jason Karpac3, Robert S Chapkin8,9.   

Abstract

Ras signaling originates from transient nanoscale compartmentalized regions of the plasma membrane composed of specific proteins and pan class="Chemical">lipids. The highly specific n>n class="Chemical">lipid composition of these nanodomains, termed nanoclusters, facilitates effector recruitment and therefore influences signal transduction. This suggests that Ras nanocluster proteolipid composition could represent a novel target for future chemoprevention interventions. There is evidence that consumption of fish oil containing long-chain n-3 polyunsaturated fatty acids (n-3 PUFA) such as eicosapentaenoic acid (EPA, 20:5Δ5,8,11,14,17) and docosahexaenoic acid (DHA, 22:6Δ4,7,10,13,16,19) may reduce colon cancer risk in humans, yet the mechanism underlying this effect is unknown. Here, we demonstrate that dietary n-3 PUFA reduce the lateral segregation of cholesterol-dependent and -independent nanoclusters, suppressing phosphatidic acid-dependent oncogenic KRas effector interactions, via their physical incorporation into plasma membrane phospholipids. This results in attenuation of oncogenic Ras-driven colonic hyperproliferation in both Drosophila and murine models. These findings demonstrate the unique properties of dietary n-3 PUFA in the shaping of Ras nanoscale proteolipid complexes and support the emerging role of plasma membrane-targeted therapies.Significance: The influence of dietary long chain n-3 polyunsaturated fatty acids on plasma membrane protein nanoscale organization and KRas signaling supports development of plasma membrane-targeted therapies in colon cancer.Graphical Abstract: http://cancerres.aacrjournals.org/content/canres/78/14/3899/F1.large.jpg Cancer Res; 78(14); 3899-912. ©2018 AACR. ©2018 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29769200      PMCID: PMC6050089          DOI: 10.1158/0008-5472.CAN-18-0324

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  54 in total

Review 1.  Regulatory activity of polyunsaturated fatty acids in T-cell signaling.

Authors:  Wooki Kim; Naim A Khan; David N McMurray; Ian A Prior; Naisyin Wang; Robert S Chapkin
Journal:  Prog Lipid Res       Date:  2010-02-20       Impact factor: 16.195

Review 2.  Drugging the undruggable RAS: Mission possible?

Authors:  Adrienne D Cox; Stephen W Fesik; Alec C Kimmelman; Ji Luo; Channing J Der
Journal:  Nat Rev Drug Discov       Date:  2014-10-17       Impact factor: 84.694

3.  SIGNAL TRANSDUCTION. Membrane potential modulates plasma membrane phospholipid dynamics and K-Ras signaling.

Authors:  Yong Zhou; Ching-On Wong; Kwang-jin Cho; Dharini van der Hoeven; Hong Liang; Dhananiay P Thakur; Jialie Luo; Milos Babic; Konrad E Zinsmaier; Michael X Zhu; Hongzhen Hu; Kartik Venkatachalam; John F Hancock
Journal:  Science       Date:  2015-08-21       Impact factor: 47.728

4.  Bioactive products formed in humans from fish oils.

Authors:  Carsten Skarke; Naji Alamuddin; John A Lawson; Xuanwen Li; Jane F Ferguson; Muredach P Reilly; Garret A FitzGerald
Journal:  J Lipid Res       Date:  2015-07-15       Impact factor: 5.922

5.  n-3 PUFA alter caveolae lipid composition and resident protein localization in mouse colon.

Authors:  David W L Ma; Jeongmin Seo; Laurie A Davidson; Evelyn S Callaway; Yang-Yi Fan; Joanne R Lupton; Robert S Chapkin
Journal:  FASEB J       Date:  2004-04-14       Impact factor: 5.191

6.  A 22-year prospective study of fish, n-3 fatty acid intake, and colorectal cancer risk in men.

Authors:  Megan N Hall; Jorge E Chavarro; I-Min Lee; Walter C Willett; Jing Ma
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-05       Impact factor: 4.254

7.  Dose translation from animal to human studies revisited.

Authors:  Shannon Reagan-Shaw; Minakshi Nihal; Nihal Ahmad
Journal:  FASEB J       Date:  2007-10-17       Impact factor: 5.191

8.  Separation of liquid phases in giant vesicles of ternary mixtures of phospholipids and cholesterol.

Authors:  Sarah L Veatch; Sarah L Keller
Journal:  Biophys J       Date:  2003-11       Impact factor: 4.033

9.  Rapidly cycling Lgr5+ stem cells are exquisitely sensitive to extrinsic dietary factors that modulate colon cancer risk.

Authors:  Eunjoo Kim; Laurie A Davidson; Roger S Zoh; Martha E Hensel; Michael L Salinas; Bhimanagouda S Patil; Guddadarangavvanahally K Jayaprakasha; Evelyn S Callaway; Clinton D Allred; Nancy D Turner; Brad R Weeks; Robert S Chapkin
Journal:  Cell Death Dis       Date:  2016-11-10       Impact factor: 8.469

10.  A comprehensive survey of Ras mutations in cancer.

Authors:  Ian A Prior; Paul D Lewis; Carla Mattos
Journal:  Cancer Res       Date:  2012-05-15       Impact factor: 12.701

View more
  5 in total

1.  AdipoRon Attenuates Wnt Signaling by Reducing Cholesterol-Dependent Plasma Membrane Rigidity.

Authors:  Michael L Salinas; Natividad R Fuentes; Rachel Choate; Rachel C Wright; David N McMurray; Robert S Chapkin
Journal:  Biophys J       Date:  2019-09-16       Impact factor: 4.033

2.  Eicosapentaenoic acid's metabolism of 15-LOX-1 promotes the expression of miR-101 thus inhibits Cox2 pathway in colon cancer.

Authors:  Yi Cai; Jie Liu; Shao-Kang Cai; Er-Ya Miao; Cheng-Qian Jia; Yong-Zhi Fan; Ying-Bo Li
Journal:  Onco Targets Ther       Date:  2020-06-15       Impact factor: 4.147

3.  Docosahexaenoic Acid Suppresses Silica-Induced Inflammasome Activation and IL-1 Cytokine Release by Interfering With Priming Signal.

Authors:  Kathryn A Wierenga; Josephine Wee; Kristen N Gilley; Lichchavi D Rajasinghe; Melissa A Bates; Mikhail A Gavrilin; Andrij Holian; James J Pestka
Journal:  Front Immunol       Date:  2019-09-20       Impact factor: 7.561

4.  Bile acids target proteolipid nano-assemblies of EGFR and phosphatidic acid in the plasma membrane for stimulation of MAPK signaling.

Authors:  Hong Liang; Mary K Estes; Huiling Zhang; Guangwei Du; Yong Zhou
Journal:  PLoS One       Date:  2018-08-31       Impact factor: 3.240

5.  Eicosapentaenoic Acid Inhibits KRAS Mutant Pancreatic Cancer Cell Growth by Suppressing Hepassocin Expression and STAT3 Phosphorylation.

Authors:  Ching-Feng Chiu; Ming-I Hsu; Hsiu-Yen Yeh; Ji Min Park; Yu-Shiuan Shen; Te-Hsuan Tung; Jun-Jie Huang; Hung-Tsung Wu; Shih-Yi Huang
Journal:  Biomolecules       Date:  2021-03-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.